Tarsus Pharmaceuticals Expands Eye Care with Alkeus Deal
Irvine, California, USA, August 7, 2026 Tarsus Pharmaceuticals has announced a definitive agreement to acquire Alkeus Pharmaceuticals, a privately...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Irvine, California, USA, August 7, 2026 Tarsus Pharmaceuticals has announced a definitive agreement to acquire Alkeus Pharmaceuticals, a privately...
Amsterdam, Netherlands, August 7, 2026 Royal Philips has expanded its open patient monitoring ecosystem through a series of strategic...
ORLANDO, Fla., July 30, 2026 Andor Health announced that its AI-native clinical services operating platform, ThinkAndor®, has reached General...
REHOVOT, Israel, June 2, 2026 Evogene Ltd. has announced the successful completion of the first-in-human Phase 1 clinical study...
SAN DIEGO, June 1, 2026 Resmed has completed its acquisition of Noctrix Health, significantly expanding its clinical sleep health...
PALO ALTO, Calif., May 14, 2026 Glooko, Inc. announced that the U.S. Food and Drug Administration has granted 510(k)...
WARSAW, Ind., December 16, 2025 — Zimmer Biomet Holdings, Inc., a global leader in medical technology, has entered into...
